Molecular Tumor Board: 38-year-old female with follicular thyroid cancer and NRAS Q61R alteration

In our latest molecular tumor board, our Medical Affairs team conducted an in-depth review of a case of follicular thyroid cancer with an NRAS mutation. Our team delved into the critical role of molecular profiling to identify the major oncogenic mechanisms driving thyroid carcinogenesis and emphasized the importance of thorough pathological and imaging evaluations for an accurate diagnosis of thyroid cancer.